切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库（CSCD）来源期刊

高级检索
中华重症医学电子杂志

中华重症医学电子杂志 ›› 2023, Vol. 09 ›› Issue (02) : 168 -177. doi: 10.3877/cma.j.issn.2096-1537.2023.02.007

临床研究

血浆肝素结合蛋白在脓毒症早期诊断和预后预测中的应用
蔡荇, 张文娟, 於江泉, 郑瑞强†()   
  1. 225001　江苏扬州，江苏省苏北人民医院重症医学科
  • 收稿日期:2022-06-08 出版日期:2023-05-28
  • 通信作者: 郑瑞强
  • 基金资助:
    江苏省卫健委科研项目(Z2020055)

Study on the prognostic value of plasma heparin-binding protein in the early diagnosis and prognosis of sepsis

Xing Cai, Wenjuan Zhang, Jiangquan Yu, Ruiqiang Zheng†()   

  1. Department of Critical Care Medicine, Northern Jiangsu People's Hospital in Jiangsu Province, Yangzhou 225001, China
  • Received:2022-06-08 Published:2023-05-28
  • Corresponding author: Ruiqiang Zheng
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

蔡荇, 张文娟, 於江泉, 郑瑞强. 血浆肝素结合蛋白在脓毒症早期诊断和预后预测中的应用[J]. 中华重症医学电子杂志, 2023, 09(02): 168-177.

Xing Cai, Wenjuan Zhang, Jiangquan Yu, Ruiqiang Zheng. Study on the prognostic value of plasma heparin-binding protein in the early diagnosis and prognosis of sepsis[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2023, 09(02): 168-177.

目的

分析血浆肝素结合蛋白（HBP）对脓毒症的早期诊断及预后预测的价值。

方法

采用前瞻性观察性研究方法，收集2019年6月至2021年6月在江苏省苏北人民医院重症医学科确诊感染的患者198例，根据病情严重程度分为非脓毒症组（48例）、脓毒症组（52例）、脓毒症休克组（98例）。另外选择同期入住我科的40例非感染性疾病患者作为对照组。对比分析各组患者HBP、降钙素原（PCT）、C反应蛋白（CRP）、白细胞计数（WBC）、乳酸（Lac）水平的差异，绘制受试者工作特征（ROC）曲线评估各指标对脓毒症诊断及28 d生存情况的预测价值；采用logistic回归分析明确影响脓毒症预后的因素。

结果

入组时脓毒症休克组患者HBP水平显著高于其他3组，且脓毒症组患者的水平也显著高于非脓毒症组，差异有统计学意义（P＜0.05）。当取最佳截断值35.8 ng/ml时，HBP从感染群体中筛选出脓毒症患者的曲线下面积（AUC）为0.922。将所有脓毒症患者根据28 d后的存活情况分为死亡组（29例）和存活组（121例），死亡组患者的HBP和Lac水平均高于存活组，差异有统计学意义（P＜0.05），而2组间PCT、CRP和WBC比较，差异无统计学意义（P＞0.05）。当HBP＞97.6 ng/ml时，脓毒症病死率明显升高，预测患者28 d病死率的AUC为0.750，敏感度为65.5%，特异度为77.7%。死亡组在入组0、24、48、72 h血浆HBP水平均高于存活组，差异有统计学意义（P＜0.05），而死亡组血浆HBP水平在各时间点与前一时间点相比，差异均无统计学意义（P＞0.05）。

结论

HBP可作为诊断脓毒症的早期生物标志物，并且与PCT、CRP、WBC和Lac相比有更好的诊断价值。同时，HBP水平及变化趋势与脓毒症疾病严重程度相关，可用来评价脓毒症患者的预后情况。

关键词: 肝素结合蛋白, 脓毒症, 脓毒症休克, 生物标志物
Objective

To evaluate the value of plasma heparin binding protein (HBP) in the early diagnosis of sepsis, and to explore the application value of HBP for the severity and prognosis assessment of sepsis.

Methods

A prospective observational study was conducted in Department of Critical Care Medicine of Northern Jiangsu People's Hospital. One hundred and ninety-eight patients with confirmed infections from June 2019 to June 2021 were enrolled in this study. According to the illness severity of sepsis, patients were assigned as non-sepsis (n=48), sepsis (n=52) and septic shock (n=98). Forty patients in the same period without infection were selected as control group. The differences in HBP, procalcitonin (PCT), C-reactive protein (CRP), white blood cell count (WBC) and lactate (Lac) levels were compared and analyzed. The prognostic values on sepsis diagnosis and 28-day mortality were evaluated through drawing receiver operating characteristic (ROC) curve. Logistic regression analysis was used to clarify the factors affecting the prognosis of sepsis.

Results

The plasma level of HBP was obviously elevated in septic shock group than patients in other three groups (P＜0.05), while patients in sepsis group had higher HBP than patients in non-sepsis group (P＜0.05). Take an optimal cutoff value of 35.8 ng/ml, the area under the curve (AUC) for HBP to distinguish sepsis from from non-sepsis was 0.922. The levels of HBP and Lac were also significantly elevated in non-survivors compared to survival group (P＜0.05). Ho sever, no significant differences of PCT, CRP and WBC levels were found between the two groups. Plasma HBP＞97.6 ng/ml was associated with elevated mortality, AUC of HBP predicting 28-day mortality of sepsis patients was 0.750, with a sensitivity of 65.5% and a specificity of 77.7%. The plasma HBP levels in death group were higher than those in survival group at 0 h, 24 h, 48 h and 72 h after admission (P＜0.05). Meanwhile, in death group, the plasma HBP level showed no statistical differences in each time point compared with that in the previous time point (P＞0.05).

Conclusion

HBP can be a better and more specific early predictor of sepsis compared with PCT, CRP, WBC and Lactate. Meanwhile, the level and tendency of HBP has valuable to evaluate the severity of sepsis and mortality.

Key words: Heparin-binding protein, Sepsis, Septic shock, Biomarkers
表1 各组研究对象一般资料比较
一般资料 对照组（40例） 非脓毒症组（48例） 脓毒症组（52例） 脓毒症休克组（98例） 统计值 P值
年龄（岁，
x¯
±s）		 62.7±6.0 60.6±10.5 62.9±10.0 63.6±9.5 F=1.095 0.352
性别［男，例（%）］ 18（45.0） 24（50.0） 32（61.5） 52（53.1） χ2=2.722 0.736
基础疾病［例（%）］
高血压 10（25.0） 17（35.4） 12（23.1） 28（28.6） χ2=2.120 0.548
糖尿病 7（17.5） 11（22.9） 13（25.0） 31（31.6） χ2=3.378 0.337
冠心病 5（12.5） 8（16.7） 6（11.5） 19（19.4） χ2=1.991 0.574
感染来源［例（%）］
呼吸系统 - 32（66.7） 27（51.9） 50（51.0） χ2=3.466 0.177
腹腔脏器 - 4（8.3） 8（15.4） 15（15.3） χ2=1.513 0.469
泌尿系统 - 7（14.6） 10（19.2） 16（16.3） χ2=0.404 0.817
血流感染 - 0 3（5.8） 8（8.2） χ2=4.098 0.129
其他 - 5（10.4） 4（7.7） 9（9.2） χ2=0.226 0.893
APACHEⅡ评分（分，
x¯
±s）		 14.7±5.3 15.9±4.9 16.5±3.8 22.1±6.2 F=27.088 ＜0.001
图1 各组研究对象感染标志物水平的比较。图a~e分别为HBP、PCT、CRP、WBC、Lac水平注：HBP为肝素结合蛋白；PCT为降钙素原；CRP为C反应蛋白；WBC为白细胞计数；Lac为乳酸
表2 各组研究对象HBP、PCT、CRP、WBC和Lac水平比较［M（Q25，Q75）］
组别 例数 HBP（ng/ml） PCT（ng/ml） CRP（mg/L） WBC（×109/L） Lac（mmol/L）
对照组 40 7.6（5.9，10.8） 0.6（0.2，1.0） 11.0（9.1，16.9） 9.9（1.7，11.3） 2.1（1.6，2.9）
非脓毒症组 48 16.3（5.9，31.2）a 1.3（0.5，2.9）a 44.5（34.0，64.5）a 11.2（7.7，13.4） 1.6（1.1，2.5）
脓毒症组 52 36.1（29.9，45.9）ab 8.1（2.6，23.0）ab 62.1（45.3，77.8）ab 14.8（7.7，19.7）ab 2.4（1.6，3.9）ab
脓毒症休克组 98 86.9（54.9，131.0）abc 32.5（16.7，62.0）abc 101.7（74.8，144.3）abc 14.8（9.9，23.8）ab 3.2（2.3，7.0）abc
H值 168.727 145.241 162.460 26.029 41.925
P值 ＜0.001 ＜0.001 ＜0.001 ＜0.001 ＜0.001
表3 非脓毒症组、脓毒症组和脓毒症休克组0、24、48、72 h血浆HBP水平比较［ng/ml，M（Q25，Q75）］
组别 例数 0 h 24 h 48 h 72 h H值 P值
非脓毒症组 48 16.3（5.9，31.2） 11.4（5.9，20.8） 10.8（5.9，16.1） 5.9（5.9，8.4） 30.616 ＜0.001
脓毒症组 52 36.1（29.9，45.9）a 30.6（21.4，34.9）a 21.0（15.2，31.2）a 10.7（9.3，19.8）a 77.260 ＜0.001
脓毒症休克组 98 86.9（55.0，131.0）ab 56.0（35.8，89.3）ab 43.1（24.8，72.9）ab 24.6（16.2，46.7）ab 106.611 ＜0.001
H值 113.882 109.381 85.532 110.478
P值 ＜0.001 ＜0.001 ＜0.001 ＜0.001
图2 HBP、PCT、CRP、WBC和Lac从感染群体中筛选出脓毒症患者的ROC曲线注：HBP为肝素结合蛋白；PCT为降钙素原；CRP为C反应蛋白；WBC为白细胞计数；Lac为乳酸
表4 不同感染指标对脓毒症的诊断效能
感染指标 临界值 敏感度（%） 特异度（%） AUC 95%CI P值
HBP 35.8 ng/ml 84.7 87.5 0.922 0.873~0.971 ＜0.001
PCT 3.58 ng/ml 85.3 81.2 0.899 0.851~0.947 ＜0.001
CRP 66.5 mg/L 72.7 83.3 0.858 0.803~0.914 ＜0.001
WBC 13.8×109/L 56.0 83.7 0.671 0.598~0.744 ＜0.001
Lac 1.95 mmol/L 82.7 62.5 0.728 0.634~0.821 ＜0.001
图3 28 d存活组与死亡组感染标志物水平的比较。图a~e分别为HBP、PCT、CRP、WBC、Lac水平注：HBP为肝素结合蛋白；PCT为降钙素原；CRP为C反应蛋白；WBC为白细胞计数；Lac为乳酸
图4 各感染标志物预测脓毒症患者28 d病死率的ROC曲线注：HBP为肝素结合蛋白；PCT为降钙素原；CRP为C反应蛋白；WBC为白细胞计数；Lac为乳酸；ROC为受试者工作特征
表5 死亡组和存活组0、24、48、72 h血浆HBP水平［ng/ml，M（Q25，Q75）］
组别 例数 0 h 24 h 48 h 72 h H值 P值
死亡组 29 112.2（56.9，192.8） 86.0（50.1，129.0） 72.0（35.0，106.6） 66.0（38.5，89.0） 14.364 0.002
存活组 121 58.8（36.2，95.9） 41.0（28.5，66.0）a 25.0（18.5，45.1）a 17.4（10.3，24.6）a 161.165 ＜0.001
Z值 4.172 4.344 5.348 6.642
P值 ＜0.001 ＜0.001 ＜0.001 ＜0.001
表6 28 d病死率影响因素的logistic多因素回归分析
影响因素 B值 S.E.值 Wald χ2值 OR 95%CI P值
APACHEⅡ评分（分） 0.052 0.040 1.662 1.053 0.973~1.140 0.197
HBP（ng/ml） 0.008 0.003 6.569 1.008 1.002~1.014 0.010
Lac（mmol/L） 0.218 0.062 12.429 1.244 1.102~1.404 ＜0.001
1
Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J]. JAMA, 2016, 315(8): 775-787.
2
Barroqueiro ES, Prado DS, Barcellos PS, et al. Immunomodulatory and antimicrobial activity of Babassu Mesocarp improves the survival in lethal sepsis [J]. Evid Based Complement Alternat Med, 2016, 2016: 2859652.
3
Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management [J]. BMJ, 2016, 353: i1585.
4
Fleischmann C, Scherag A, Adhikari NK, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations [J]. Am J Respir Crit Care Med, 2016, 193(3): 259-272.
5
Bastani A, Galens S, Rocchini A, et al. ED identification of patients with severe sepsis/septic shock decreases mortality in a community hospital [J]. Am J Emerg Med, 2012, 30(8): 1561-1566.
6
Phan K, Huo YR, Jia F, et al. Meta-analysis of stent-assisted coiling versus coiling-only for the treatment of intracranial aneurysms [J]. J Clin Neurosci, 2016, 31: 15-22.
7
Sanaei Dashti A, Alizadeh S, Karimi A, et al. Diagnostic value of lactate, procalcitonin, ferritin, serum-C-reactive protein, and other biomarkers in bacterial and viral meningitis: A cross-sectional study [J]. Medicine (Baltimore), 2017, 96(35): e7637.
8
Bisaria S, Terrigno V, Hunter K, et al. Association of elevated levels of inflammatory marker high-sensitivity C-reactive protein and hypertension [J]. J Prim Care Community Health, 2020, 11: 2150132720984426.
9
Shafer WM, Martin LE, Spitznagel JK. Cationic antimicrobial proteins isolated from human neutrophil granulocytes in the presence of diisopropyl fluorophosphate [J]. Infect Immun, 1984, 45(1): 29-35.
10
Stjärne Aspelund A, Hammarström H, Inghammar M, et al. Heparin-binding protein, lysozyme, and inflammatory cytokines in bronchoalveolar lavage fluid as diagnostic tools for pulmonary infection in lung transplanted patients [J]. Am J Transplant, 2018, 18(2): 444-452.
11
Niu T, Liu Y, Zhu F, et al. Time-resolved fluorescent immunoassay-based combined detection of procalcitonin, C-reactive protein, heparin binding protein, and serum amyloid A1 to improve the diagnostic accuracy of early infection [J]. J Clin Lab Anal, 2019, 33(2): e22694.
12
Kahn F, Tverring J, Mellhammar L, et al. Heparin-binding protein as a prognostic biomarker of sepsis and disease severity at the Emergency Department [J]. Shock, 2019, 52(6): e135-e145.
13
Liu XW, Ma T, Liu W, et al. Sustained increase in angiopoietin-2, heparin-binding protein, and procalcitonin is associated with severe sepsis [J]. J Crit Care, 2018, 45: 14-19.
14
Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J]. JAMA, 2016, 315(8): 801-810.
15
Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 [J]. Intensive Care Med, 2017, 43(3): 304-377.
16
Khwannimit B, Bhurayanontachai R, Vattanavanit V. Comparison of the accuracy of three early warning scores with SOFA score for predicting mortality in adult sepsis and septic shock patients admitted to intensive care unit [J]. Heart Lung, 2019, 48(3): 240-244.
17
Tapper H, Karlsson A, Mörgelin M, et al. Secretion of heparin-binding protein from human neutrophils is determined by its localization in azurophilic granules and secretory vesicles [J]. Blood, 2002, 99(5): 1785-1793.
18
Wu YL, Yo CH, Hsu WT, et al. Accuracy of heparin-binding protein in diagnosing sepsis: a systematic review and meta-analysis [J]. Crit Care Med, 2021, 49(1): e80-e90.
19
Skondra D, Noda K, Almulki L, et al. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown [J]. Invest Ophthalmol Vis Sci, 2008, 49(2): 726-731.
20
Bentzer P, Fisher J, Kong HJ, et al. Heparin-binding protein is important for vascular leak in sepsis [J]. Intensive Care Med Exp, 2016, 4(1): 33.
21
Gautam N, Olofsson AM, Herwald H, et al. Heparin-binding protein (HBP/CAP37): a missing link in neutrophil-evoked alteration of vascular permeability [J]. Nat Med, 2001, 7(10): 1123-1127.
22
Raghu H, Lepus CM, Wang Q, et al. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis [J]. Ann Rheum Dis, 2017, 76(5): 914-922.
23
Chang M, Guo F, Zhou Z, et al. HBP induces the expression of monocyte chemoattractant protein-1 via the FAK/PI3K/AKT and p38 MAPK/NF-κB pathways in vascular endothelial cells [J]. Cell Signal, 2018, 43: 85-94.
24
Heinzelmann M, Kim E, Hofmeister A, et al. Heparin binding protein (CAP37) differentially modulates endotoxin-induced cytokine production [J]. Int J Surg Investig, 2001, 2(6): 457-466.
25
Soehnlein O, Weber C, Lindbom L. Neutrophil granule proteins tune monocytic cell function [J]. Trends Immunol, 2009, 30(11): 538-546.
26
Zhou Y, Liu Z, Huang J, et al. Usefulness of the heparin-binding protein level to diagnose sepsis and septic shock according to Sepsis-3 compared with procalcitonin and C reactive protein: a prospective cohort study in China [J]. BMJ Open, 2019, 9(4): e026527.
27
Funke A, Berner R, Traichel B, et al. Frequency, natural course, and outcome of neonatal neutropenia [J]. Pediatrics, 2000, 106(1 Pt 1): 45-51.
28
Linder A, Christensson B, Herwald H, et al. Heparin-binding protein: an early marker of circulatory failure in sepsis [J]. Clin Infect Dis, 2009, 49(7): 1044-1050.
29
Katsaros K, Renieris G, Safarika A, et al. Heparin binding protein for the early diagnosis and prognosis of sepsis in the Emergency Department: the prompt multicenter study [J]. Shock, 2022, 57(4): 518-525.
30
Linder A, Åkesson P, Inghammar M, et al. Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock [J]. Crit Care, 2012, 16(3): R90.
31
Chew MS, Linder A, Santen S, et al. Increased plasma levels of heparin-binding protein in patients with shock: a prospective, cohort study [J]. Inflamm Res, 2012, 61(4): 375-379.
32
Shrotri MS, Kuhn JF, Peyton JC, et al. Heparin-binding protein decreases apoptosis in human and murine neutrophils [J]. J Surg Res, 2000, 89(1): 53-59.
33
Fisher J, Kahn F, Wiebe E, et al. The dynamics of circulating heparin-binding protein: implications for its use as a biomarker [J]. J Innate Immun, 2021, 29: 1-14.
[1] 韩媛媛, 热孜亚·萨贝提, 冒智捷, 穆福娜依·艾尔肯, 陆晨, 桑晓红, 阿尔曼·木拉提, 张丽. 组合式血液净化治疗对脓毒症患者血清炎症因子水平和临床预后的影响[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 272-278.
[2] 罗丹, 孔为民, 陈姝宁, 赵小玲, 谢云凯. 子宫内膜异位症患者在位及异位内膜上皮细胞-间充质转化相关生物标志物的变化[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 530-539.
[3] 张晓燕, 肖东琼, 高沪, 陈琳, 唐发娟, 李熙鸿. 转录因子12过表达对脓毒症相关性脑病大鼠大脑皮质的保护作用及其机制[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 540-549.
[4] 代雯荣, 赵丽娟, 李智慧. 细胞外囊泡对胚胎着床影响的研究进展[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 616-620.
[5] 魏徐, 张鸽, 伍金林. 新生儿脓毒症相关性凝血病的监测和治疗[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 379-386.
[6] 姚咏明. 如何精准评估烧伤脓毒症患者免疫状态[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 552-552.
[7] 李越洲, 张孔玺, 李小红, 商中华. 基于生物信息学分析胃癌中PUM的预后意义[J]. 中华普通外科学文献(电子版), 2023, 17(06): 426-432.
[8] 李腾成, 狄金明. 2023 V1版前列腺癌NCCN指南更新要点解读[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 313-318.
[9] 窦上文, 邓欢, 刘邦锋, 岳高远志, 朱华财, 刘永达. 术前复查尿培养在预测微通道经皮肾镜取石术相关感染并发症中的作用[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 361-366.
[10] 陈坤, 何傅梅, 方婷, 陈文瑞. 血清sCD73与EGFR/ALK野生型非小细胞肺癌免疫治疗效果的相关性分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 504-507.
[11] 李伟, 卓剑, 黄川, 黄有攀. Lac、HO-1、sRAGE、CRP/ALB表达及脓毒症并发ARDS危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 514-516.
[12] 陈安, 冯娟, 杨振宇, 杜锡林, 柏强善, 阴继凯, 臧莉, 鲁建国. 基于生物信息学分析CCN4在肝细胞癌中表达及其临床意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 702-707.
[13] 吴蓉菊, 向平超. COPD频繁急性加重表型与炎性因子相关性研究[J]. 中华临床医师杂志(电子版), 2023, 17(9): 939-947.
[14] 谭睿, 王晶, 於江泉, 郑瑞强. 脓毒症中高密度脂蛋白、载脂蛋白A-I和血清淀粉样蛋白A的作用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(06): 749-753.
[15] 郭芳芳, 李珉珉. 狼疮肾炎无创生物标志物的研究进展[J]. 中华诊断学电子杂志, 2023, 11(04): 271-275.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号